Key result
Genetically predicted abundance of specific gut flora, such as Family XIII (OR 0.87), and serum metabolites demonstrated potential causal associations with the risk of developing atrial fibrillation.
Why the study?
Emerging evidence suggests links between gut flora, serum metabolites, and specific arrhythmias, but potential causal associations remained unclarified.
Do genetically predicted gut flora and serum metabolites causally affect the risk of developing various cardiac arrhythmias?
Observational (n=1,030,836)
Mendelian randomization
Yes
Do genetically predicted gut flora and serum metabolites causally affect the risk of developing various cardiac arrhythmias?
Odds Ratio: 0.87 (95% CI 0.8–0.94)
p-value: p=0.0005
This Mendelian randomization study identifies potential causal relationships between specific gut flora, serum metabolites, and the risk of various cardiac arrhythmias, providing novel theoretical targets for future research.
Mendelian randomization links gut flora and metabolites to arrhythmias; leaves open whether these inform prevention or require prospective validation.
BACKGROUND: The pathogenesis of cardiac arrhythmias is multifaceted, encompassing genetic, environmental, hemodynamic, and various causative factors. Emerging evidence underscores a plausible connection between gut flora, serum metabolites, and specific types of arrhythmias. Recognizing the role of host genetics in shaping the microbiota, we employed two-sample Mendelian randomization analyses to investigate potential causal associations between gut flora, serum metabolites, and distinct arrhythmias. METHODS: Mendelian randomization methods were deployed to ascertain causal relationships between 211 gut flora, 575 serum metabolites, and various types of arrhythmias. To ensure the reliability of the findings, five complementary Mendelian randomization methods, including inverse variance weighting methods, were employed. The robustness of the results was scrutinized through a battery of sensitivity analyses, incorporating the Cochran Q test, leave-one-out test, and MR-Egger intercept analysis. RESULTS: Eighteen gut flora and twenty-six serum metabolites demonstrated associations with the risk of developing atrial fibrillation. Moreover, ten gut flora and fifty-two serum metabolites were linked to the risk of developing supraventricular tachycardia, while eight gut flora and twenty-five serum metabolites were associated with the risk of developing tachycardia. Additionally, six gut flora and twenty-one serum metabolites exhibited associations with the risk of developing bradycardia. CONCLUSION: This study revealed the potential causal relationship that may exist between gut flora, serum metabolites and different cardiac arrhythmias and highlights the need for further exploration. This study provides new perspectives to enhance diagnostic and therapeutic strategies in the field of cardiac arrhythmias.
No takes yet. Share an insight, caveat, or question.
Li et al. (2024) conducted an observational in Arrhythmia (n=1,030,836). Gut flora and serum metabolites vs. Unexposed/reference genetic variants was evaluated on Atrial fibrillation (OR 0.87, 95% CI 0.80-0.94, p=0.0005). Genetically predicted abundance of specific gut flora, such as Family XIII (OR 0.87), and serum metabolites demonstrated potential causal associations with the risk of developing atrial fibrillation.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: